Stock Screener App

Gratuito -

Installare

4.99

3.48% -0.18

after-market

Dopo l'orario di chiusura: 5.00 0.010 +0.20%

Atara Biotherapeutics Inc (ATRA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ATRA Giù? Forum Previsione

Atara Biotherapeutics Inc Borsa (ATRA) Ultime notizie

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Atara Biotherapeutics, Inc. (ATRA) registers possible resale of 400K common shares tied to HCR warrant exercise - MSN

Securities Fraud Investigation Into Atara Biotherapeutics, Inc - The National Law Review

ATRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit - Lelezard

ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - Sahm

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure ... - Black Hills Pioneer

ROSEN Counsel Encourages Atara Biotherapeutics Investors to Act - National Today

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Atara - GlobeNewswire

ATRA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire

ATRA Technical Analysis & Stock Price Forecast - Intellectia AI

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

ATRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Atara Biotherapeutics, Inc. (ATRA) Registers Possible Resale of 400K Common Shares Tied to HCR Warrant Exercise - Yahoo Finance

Aug Sectors: Is Atara Biotherapeutics Inc being accumulated by smart moneyWeekly Profit Report & Smart Investment Allocation Tips - baoquankhu1.vn

Deadline Alert: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - The Norfolk Daily News

DEADLINE ALERT for LU, ATRA, and COTY: The Law Offices of - GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Atara - GlobeNewswire

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain OfficersATRA - PR Newswire

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Atara Biotherapeutics Faces Class Action Lawsuit - Intellectia AI

ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors ... - Bluefield Daily Telegraph

Atara Biotherapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 22, 2026 to Discuss Your RightsATRA - marketscreener.com

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx - GlobeNewswire Inc.

2026-04-01 | ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ATRA | Press Release - Stockhouse

ATRA Stock Price, Quote & Chart | ATARA BIOTHERAPEUTICS INC (NASDAQ:ATRA) - ChartMill

Did You Lose Money Investing in Atara Biotherapeutics, - GlobeNewswire

Pomerantz Law Firm Files Class Action Against Atara Biotherapeutics - National Today

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics Lawsuit - National Today

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph

Holzer & Holzer, LLC Reminds Investors of Lead Plaintiff - GlobeNewswire

Law Offices of Frank R. Cruz Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action - Business Wire

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff Deadline in - GuruFocus

ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff Deadline in Atara Biotherapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm - Morningstar

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Atara Biotherapeutic - The National Law Review

Atara Biotherapeutics | 10-K: FY2025 Annual Report - Moomoo

Class Action Filed Against Atara Biotherapeutics, Inc. (ATRA) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire

ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure ... - Black Hills Pioneer

ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Bioth - GuruFocus

ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - ChartMill

ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Law Offices of Howard G. Smith Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action - ChartMill

Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire

ATRA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Atara ... - Bluefield Daily Telegraph

ATRA Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

ATRA Class Action ReminderRobbins LLP Reminds Investors - GlobeNewswire

Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal

Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - ChartMill

FinancialContentAtara Biotherapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – ATRA - markets.financialcontent.com

[EFFECT] Atara Biotherapeutics, Inc. SEC Filing - Stock Titan

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Atara - GlobeNewswire

Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal

Atara Biotherapeutics (ATRA) registers 400,000 shares for resale by HCR - Stock Titan

Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors - GlobeNewswire

RVMD

$99.12

0.49%

ROIV

$28.33

1.76%

RPRX

$48.57

0.16%

BNTX

$91.18

1.97%

ONC

$310.79

0.76%

INSM

$162.43

1.47%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters